Literature DB >> 12181351

Molecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosis.

Bin Zhou1, Janet A Weigel, Amit Saxena, Paul H Weigel.   

Abstract

We recently purified the rat liver hyaluronan receptor for endocytosis (HARE) and found abundant expression of 175- and approximately 300-kDa HARE species in sinusoidal endothelial cells of the liver, spleen, and lymph nodes. We report herein the first cloning and functional expression of the rat 175-kDa HARE. Peptide sequences were obtained from the purified 175-kDa HARE, and degenerate oligonucleotide primers were designed for reverse transcription-polymerase chain reaction and cDNA cloning. Results of 5'-rapid amplification of cDNA ends, Northern analysis, N-terminal sequence, and antibody reactivity analyses indicated the absence of mRNA directly encoding the 175-kDa HARE. This protein is most likely derived from a larger precursor. Accordingly, we constructed an artificial 4.7-kb cDNA encoding the 1431 amino acid 175-kDa HARE. The predicted type I membrane protein has a mass of 156,393 Da and a pI of 7.86. The 175-kDa HARE cDNA, fused to the N-terminal leader sequence of the Ig kappa-chain, was transfected transiently into COS-7 cells and stably into SK-Hep-1 cells, respectively, to assess hyaluronan or hyaluronic acid (HA)-binding activity and endocytosis. In both cases, HARE expression and HA-binding activity were detected. Furthermore, stable SK-175HARE cells demonstrated specific endocytosis of (125)I-HA and receptor recycling. Fluorescence-activated cell sorting analysis confirmed that recombinant HARE was expressed on the cell surface and that fluorescent HA uptake was inhibited by a specific blocking monoclonal antibody against HARE. Additionally, HARE was substantially colocalized with clathrin, but not with internalized HA that was delivered to lysosomes. The results confirm that recombinant 175-kDa HARE is an authentic endocytic receptor for HA and that this receptor can function independently of the approximately 300-kDa HARE. HARE is the first functionally identified member of a protein family that shares a similar organization of Fasciclin, epidermal growth factor-like, Xlink, and transmembrane domains.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181351      PMCID: PMC117947          DOI: 10.1091/mbc.02-03-0048

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  59 in total

1.  Molecular mechanisms of cell motility.

Authors:  E A Turley
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

Review 2.  Endocytosis and molecular sorting.

Authors:  I Mellman
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

3.  A novel ligand blot assay detects different hyaluronan-binding proteins in rat liver hepatocytes and sinusoidal endothelial cells.

Authors:  J Yannariello-Brown; B Zhou; D Ritchie; J A Oka; P H Weigel
Journal:  Biochem Biophys Res Commun       Date:  1996-01-05       Impact factor: 3.575

4.  The chondrodystrophy, nanomelia: biosynthesis and processing of the defective aggrecan precursor.

Authors:  B M Vertel; B L Grier; H Li; N B Schwartz
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

5.  Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably in rheumatoid arthritis patients who have begun activity after a night of bed rest.

Authors:  D H Manicourt; P Poilvache; A Nzeusseu; A van Egeren; J P Devogelaer; M E Lenz; E J Thonar
Journal:  Arthritis Rheum       Date:  1999-09

6.  Identification of the Ca(2+)-independent endocytic hyaluronan receptor in rat liver sinusoidal endothelial cells using a photoaffinity cross-linking reagent.

Authors:  J Yannariello-Brown; S J Frost; P H Weigel
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

Review 7.  Hyaluronan-binding proteins in development, tissue homeostasis, and disease.

Authors:  C B Knudson; W Knudson
Journal:  FASEB J       Date:  1993-10       Impact factor: 5.191

8.  Hyaluronic acid in progressive systemic sclerosis.

Authors:  J P Freitas; P Filipe; I Emerit; P Meunier; C F Manso; F Guerra Rodrigo
Journal:  Dermatology       Date:  1996       Impact factor: 5.366

Review 9.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

10.  Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.

Authors:  B Yang; B L Yang; R C Savani; E A Turley
Journal:  EMBO J       Date:  1994-01-15       Impact factor: 11.598

View more
  27 in total

Review 1.  Brain extracellular space, hyaluronan, and the prevention of epileptic seizures.

Authors:  Katherine L Perkins; Amaia M Arranz; Yu Yamaguchi; Sabina Hrabetova
Journal:  Rev Neurosci       Date:  2017-11-27       Impact factor: 4.353

2.  Distinctive properties of the hyaluronan-binding domain in the lymphatic endothelial receptor Lyve-1 and their implications for receptor function.

Authors:  Suneale Banerji; Branwen R S Hide; John R James; Martin E M Noble; David G Jackson
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

Review 3.  Biology and biotechnology of hyaluronan.

Authors:  Manuela Viola; Davide Vigetti; Evgenia Karousou; Maria Luisa D'Angelo; Ilaria Caon; Paola Moretto; Giancarlo De Luca; Alberto Passi
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

Review 4.  Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.

Authors:  Colton M Miller; Michael Tanowitz; Aaron J Donner; Thazha P Prakash; Eric E Swayze; Edward N Harris; Punit P Seth
Journal:  Nucleic Acid Ther       Date:  2018-02-09       Impact factor: 5.486

5.  Tissue-specific splice variants of HARE/Stabilin-2 are expressed in bone marrow, lymph node, and spleen.

Authors:  Amanda K Hare; Edward N Harris
Journal:  Biochem Biophys Res Commun       Date:  2014-11-24       Impact factor: 3.575

6.  The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.

Authors:  Svetlana V Kyosseva; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

7.  The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans.

Authors:  Madhu S Pandey; Bruce A Baggenstoss; Jennifer Washburn; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

8.  Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.

Authors:  Edward N Harris; Bruce A Baggenstoss; Paul H Weigel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

9.  The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalization.

Authors:  Madhu S Pandey; Edward N Harris; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-06-06       Impact factor: 5.157

10.  The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin.

Authors:  Edward N Harris; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.